Research • 04.17.2023
Markups for Drugs Cost Patients Thousands of Dollars
PDF Included • 2 Pages
Issues
High-Price Drugs
Our Position
Everyone should be able to get the medications they need at a cost they can afford. But drug prices are out of control, and hardworking families feel the consequences every day. It’s time to hold Big Pharma accountable for the prices that they, and they alone, set and increase year after year.
Health insurance providers fight against Big Pharma’s price gouging for more affordable medications for Americans. We do not have to choose between innovation and affordability. With the right solutions, Americans can have both.
Go to
Resources
Research • 04.03.2023
State Law Chart • 01.19.2023
Policy • 09.20.2022
Policy • 09.19.2022
Comment Letter • 05.25.2022
Events
Conference
2024 Medicare, Medicaid, Duals & Commercial Markets Forum
- Date:
- Mar 12 - 14, 2024
Webinar
Creating Better Health Outcomes with Digital Tools and Artificial Intelligence
- Date:
- Dec 8, 2023 • 12:00 – 1:00 pm EST
Webinar
Don't Go It Alone: Maximizing Partnerships for Health Plan Success
- Date:
- Dec 13, 2023 • 1:00 – 2:00 pm EST
News
08.17.2023
Sticker Shock: New Research Shows an Average List Price Increase of Over 200% for Top Part D Drugs
Getting the Facts: Big Pharma Increasingly Using Patent Games to Avoid Competition
A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.
New Health Affairs Study: Competition In Pharmaceuticals Leads to Lower Prices, Reduced Drug Spending
A study published in Health Affairs found that new brand-name pharmaceutical competition resulted in decreases in net prices of existing drugs.
AHIP State Contacts
Find contact information for AHIP state affairs staff and view state-specific resources.
View States